FWD Hong Kong Launches "Renjin Medical Insurance Plan" and Partners with Hong Kong Pharmaceutical Care Foundation

Stock News
08/18

FWD Hong Kong announced the launch of its "Renjin Medical Insurance Plan," integrating Environmental, Social, and Governance (ESG) strategies into product design and development to provide flexible and affordable medical coverage for the general public through innovative product concepts. FWD simultaneously announced a partnership with the Hong Kong Pharmaceutical Care Foundation to offer market-first pharmaceutical consultation and management services for "Renjin" insurance and designated medical insurance product customers, further enhancing customers' health management experience.

According to a previous survey by the Hong Kong Census and Statistics Department, more than half of Hong Kong residents do not have personal medical insurance, highlighting a significant medical coverage gap in the market. Relying solely on public hospital coverage may also underestimate out-of-pocket treatment and medication expenses. In response to this situation, FWD launched "Renjin" insurance to fill this coverage gap, targeting self-funded medications and medical services not subsidized by public hospitals, and providing coverage for imaging tests conducted at private medical institutions upon referral, enabling more citizens to access appropriate medical support.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10